Showing 1 - 5 of 5 Research Library Publications
Posted: | Kimberly Hu, Patricia J. Hicks, Melissa Margolis, Carol Carraccio, Amanda Osta, Marcia L. Winward, Alan Schwartz

Academic Medicine: Volume 95 - Issue 11S - Pages S89-S94

 

Semiannually, U.S. pediatrics residency programs report resident milestone levels to the Accreditation Council for Graduate Medical Education (ACGME). The Pediatrics Milestones Assessment Collaborative (PMAC) developed workplace-based assessments of 2 inferences. The authors compared learner and program variance in PMAC scores with ACGME milestones.

Posted: | F.S. McDonald, D. Jurich, L.M. Duhigg, M. Paniagua, D. Chick, M. Wells, A. Williams, P. Alguire

Academic Medicine: September 2020 - Volume 95 - Issue 9 - p 1388-1395

 

This article aims to assess the correlations between United States Medical Licensing Examination (USMLE) performance, American College of Physicians Internal Medicine In-Training Examination (IM-ITE) performance, American Board of Internal Medicine Internal Medicine Certification Exam (IM-CE) performance, and other medical knowledge and demographic variables.

Posted: | L. E. Peterson, J. R. Boulet, B. E. Clauser

Academic Medicine: Volume 95 - Issue 9 - p 1396-1403

 

The objective of this study was to evaluate the associations of all required standardized examinations in medical education with ABFM certification examination scores and eventual ABFM certification.

Posted: | S. H. Felgoise, R. A. Feinberg, H. B. Stephens, P. Barkhaus, K. Boylan, J. Caress, Z. Simmons

Muscle Nerve, 58: 646-654

 

The Amyotrophic Lateral Sclerosis (ALS)‐Specific Quality of Life instrument and its revised version (ALSSQOL and ALSSQOL‐R) have strong psychometric properties, and have demonstrated research and clinical utility. This study aimed to develop a short form (ALSSQOL‐SF) suitable for limited clinic time and patient stamina.

Posted: | M. C. Edwards, A. Slagle, J. D. Rubright, R. J. Wirth

Qual Life Res 27, 1711–1720 (2018)

 

The US Food and Drug Administration (FDA), as part of its regulatory mission, is charged with determining whether a clinical outcome assessment (COA) is “fit for purpose” when used in clinical trials to support drug approval and product labeling. This paper provides a review (and some commentary) on the current state of affairs in COA development/evaluation/use with a focus on one aspect: How do you know you are measuring the right thing? In the psychometric literature, this concept is referred to broadly as validity and has itself evolved over many years of research and application.